Skip to main content

Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.

Publication ,  Journal Article
Lee, K-M; Choi, J-Y; Park, SK; Chung, H-W; Ahn, B; Yoo, K-Y; Han, W; Noh, D-Y; Ahn, S-H; Kim, H; Wei, Q; Kang, D
Published in: Cancer Epidemiol Biomarkers Prev
April 2005

To evaluate the role of genetic polymorphisms of ataxia telangiectasia mutated (ATM) in the etiology of breast cancer, a hospital-based case-control study was conducted in Korea. Nine-hundred ninety-six histologically confirmed incident breast cancer cases and 1,181 cancer-free controls were recruited in Seoul between 1995 and 2003. Genotypes of the ATM polymorphisms-5144A > T, IVS21 + 1049T > C, IVS33 - 55T > C, IVS34 + 60G > A, and 3393T > G were determined by the 5'-nuclease assay. Individual haplotypes were estimated from genotype data by a Bayesian method. Five ATM alleles were found to be in strong linkage disequilibrium (D' > 0.82; P < 0.001). Haplotype frequencies were significantly different between cases and controls (chi2 test, P < 0.001). The ATM IVS21 + 1049 TC or CC, IVS34 + 60 GA or AA, and 3393 TG or GG genotypes were associated with increased breast cancer risk, particularly in premenopausal women [odds ratios (OR), 1.51; 95% confidence interval (CI), 1.11-2.05; OR, 1.42; 95% CI, 1.08-1.88; and OR, 1.37; 95% CI, 1.04-1.80, respectively]. Compared with diploid of TCCAG:TCCAG, the most common haplotype, the ATTGT:ATTGT was associated with decreased risk of breast cancer with borderline significance (OR, 0.77; 95% CI, 0.58-1.04) and TCCAG:ATCGT and ATTGT:ACCAG were associated with increased breast cancer risk (OR, 2.30; 95% CI, 1.18-4.48 and OR, 2.43; 95% CI, 1.1.07-5.52, respectively) after adjusting for age, education, age at first full-term pregnancy, parity, family history of breast cancer, alcohol consumption, and smoking. As the number of ATTGT haplotype decreased, the risk of breast cancer increased (P for trend < 0.01). Our results thus suggest that genetic polymorphisms of ATM play an important role in the development of breast cancer in Korean women.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

ISSN

1055-9965

Publication Date

April 2005

Volume

14

Issue

4

Start / End Page

821 / 825

Location

United States

Related Subject Headings

  • Tumor Suppressor Proteins
  • Risk Factors
  • Protein Serine-Threonine Kinases
  • Premenopause
  • Postmenopause
  • Polymorphism, Single Nucleotide
  • Polymorphism, Genetic
  • Middle Aged
  • Korea
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, K.-M., Choi, J.-Y., Park, S. K., Chung, H.-W., Ahn, B., Yoo, K.-Y., … Kang, D. (2005). Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 14(4), 821–825. https://doi.org/10.1158/1055-9965.EPI-04-0330
Lee, Kyoung-Mu, Ji-Yeob Choi, Sue Kyung Park, Hye-Won Chung, Byungchan Ahn, Keun-Young Yoo, Wonshik Han, et al. “Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.Cancer Epidemiol Biomarkers Prev 14, no. 4 (April 2005): 821–25. https://doi.org/10.1158/1055-9965.EPI-04-0330.
Lee K-M, Choi J-Y, Park SK, Chung H-W, Ahn B, Yoo K-Y, et al. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):821–5.
Lee, Kyoung-Mu, et al. “Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.Cancer Epidemiol Biomarkers Prev, vol. 14, no. 4, Apr. 2005, pp. 821–25. Pubmed, doi:10.1158/1055-9965.EPI-04-0330.
Lee K-M, Choi J-Y, Park SK, Chung H-W, Ahn B, Yoo K-Y, Han W, Noh D-Y, Ahn S-H, Kim H, Wei Q, Kang D. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):821–825.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

ISSN

1055-9965

Publication Date

April 2005

Volume

14

Issue

4

Start / End Page

821 / 825

Location

United States

Related Subject Headings

  • Tumor Suppressor Proteins
  • Risk Factors
  • Protein Serine-Threonine Kinases
  • Premenopause
  • Postmenopause
  • Polymorphism, Single Nucleotide
  • Polymorphism, Genetic
  • Middle Aged
  • Korea
  • Humans